An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
CONMED promoted Patrick Beyer to Chief Operating Officer, expanding his responsibilities to lead commercial businesses, operations, distribution, regulatory affairs, and customer excellence. Mr. Beyer's promotion reflects his track record of driving above-market growth and expanding the company's presence in key markets.
CONMED ha promosso Patrick Beyer a Direttore Operativo, ampliando le sue responsabilità alla guida degli affari commerciali, delle operazioni, della distribuzione, degli affari regolatori e dell'eccellenza del servizio clienti. La promozione del signor Beyer riflette il suo storico di risultati che superano le aspettative di mercato e di espansione della presenza dell'azienda nei mercati chiave.
CONMED ha promovido a Patrick Beyer a Director de Operaciones, expandiendo sus responsabilidades para liderar los negocios comerciales, las operaciones, la distribución, los asuntos regulatorios y la excelencia del cliente. La promoción del Sr. Beyer refleja su historial de generar crecimiento por encima del mercado y de expandir la presencia de la compañía en mercados clave.
CONMED는 패트릭 베이어를 최고운영책임자(COO)로 승진시켜, 상업 사업, 운영, 유통, 규제 사무, 고객 만족 부문을 이끌 책임을 확대하였습니다. 베이어 씨의 승진은 시장 평균을 웃도는 성장을 주도하고 핵심 시장에서 회사의 입지를 확장한 그의 경력을 반영합니다.
CONMED a promu Patrick Beyer au poste de Directeur des Opérations, élargissant ses responsabilités à la direction des affaires commerciales, des opérations, de la distribution, des affaires réglementaires et de l'excellence client. La promotion de M. Beyer reflète son bilan de croissance supérieure au marché et d'expansion de la présence de l'entreprise dans les marchés clés.
CONMED hat Patrick Beyer zum Chief Operating Officer befördert, wobei seine Verantwortlichkeiten nun die Leitung der Geschäftstätigkeiten, Betrieb, Distribution, regulatorische Angelegenheiten und Kundenzufriedenheit umfassen. Beyers Beförderung spiegelt seine Erfolgsbilanz wider, die überdurchschnittliches Marktwachstum und die Erweiterung der Unternehmenspräsenz in Schlüsselmärkten zeigt.
Positive
None.
Negative
None.
LARGO, Fla.--(BUSINESS WIRE)--
CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.
“Pat has been invaluable in driving CONMED’s above-market growth and expanding our presence in key markets,” commented Curt R. Hartman, CONMED’s Chair of the Board, President, and Chief Executive Officer. “He is an experienced leader with a proven track record of commercial and operational excellence and delivering results, and I look forward to Pat’s continued impact on the organization.”
“I am excited to take on this important leadership role at CONMED and to continue contributing to the Company’s innovation and success,” said Mr. Beyer. “I look forward to continuing to work with the team to build on CONMED’s legacy of delivering high-quality products and creating value for physicians and patients around the world.”
Mr. Beyer joined CONMED in 2014 as President of International. In October 2020, Mr. Beyer was promoted to President of International and Global Orthopedics, where he took on the added responsibilities for the Company’s Global Orthopedics R&D and U.S. Orthopedics commercial business. In 2022, Mr. Beyer led the process of acquiring both In2Bones and BioRez. Prior to CONMED, Mr. Beyer spent 21 years at Stryker in leadership roles of increasing progression and nearly four years as CEO of ICNet International. He holds a B.A. in Economics from Kalamazoo College and an M.B.A from Western Michigan University. Mr. Beyer also completed the Advanced Management Program at Harvard University.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
CONMED Corporation
Todd W. Garner
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source: CONMED Corporation
FAQ
Who has been promoted to Chief Operating Officer at CONMED ?
Patrick Beyer has been promoted to Chief Operating Officer at CONMED
What additional responsibilities will Patrick Beyer take on in his new role?
In his new role as Chief Operating Officer, Patrick Beyer will be responsible for leading the Company's commercial businesses, operations, distribution, regulatory affairs / quality assurance, and customer excellence.
When did Patrick Beyer join CONMED ?
Patrick Beyer joined CONMED in 2014.
What acquisitions did Patrick Beyer lead in 2022?
In 2022, Patrick Beyer led the process of acquiring both In2Bones and BioRez.
What is Patrick Beyer's educational background?
Patrick Beyer holds a B.A. in Economics from Kalamazoo College, an M.B.A from Western Michigan University, and completed the Advanced Management Program at Harvard University.
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
